Odo Köster
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Odo Köster has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Carsten Lukas
Ruhr University Bochum, St. Josef Hospital, Institute of Neuroradiology, Bochum, Germany
2 shared publications - Barbara Bellenberg
Institute of Neuroradiology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany
1 shared publication - Christian Ahlborn
Institute of Neuroradiology, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, 44791, Bochum, Germany
1 shared publication - Patrick Kruczek
Institute of Neuroradiology, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, 44791, Bochum, Germany.
1 shared publication - Ralf Gold
Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Bochum, Germany
1 shared publication - Robert Drescher
Institute of Diagnostic and Interventional Radiology and Nuclear Medicine, Ruhr-University Bochum, St Josef University Hospital, Bochum, Germany
1 shared publication
Latest Publications
- 2 January 2020
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 31 (1) , 225-234
Developmental Venous Anomalies are More Common in Patients with Multiple Sclerosis and Clinically Isolated Syndrome
Purpose Developmental venous anomalies (DVA) are congenital malformations of veins that drain brain parenchyma, with a prevalence up to 9.3% in normal populations and 29.5% in multiple sclerosis (MS) patients. Study purpose was to determine prevalence of DVAs in patients with clinically isolated syndrome (CIS) and early relapsing-remitting multiple sclerosis (RRMS) and to assess whether DVAs are related to altered clinical, magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) laboratory parameters. Methods Routine neurological and MRI examinations took place in a single center in 93 patients (39 CIS, 54 RRMS). Clinical disability (n = 93), MRI (n ≤ 90), CSF (n ≤ 82) parameters and DVA status were determined and compared statistically. Results A total of 29 DVAs were detected in 25 patients (25/93; 26.9%), 10 in 39 CIS patients and 15 in 54 RRMS patients. Most parameters were not significantly altered in patients with DVAs; no associated higher conversion rates from CIS to MS at 1–year (p = 0.411) or 2‑year follow-up (p = 0.281) were registered. Conclusion A higher prevalence of DVAs was detected in CIS and early MS patients than reported in non-MS populations, congruent to recent literature. The DVAs were not associated with significantly altered clinical outcomes, brain atrophy rates or disease progression, and no associated higher risk of CIS patients for converting to MS was found.
- 2 January 2020
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 31 (1) , 225-234
Developmental Venous Anomalies are More Common in Patients with Multiple Sclerosis and Clinically Isolated Syndrome
Purpose Developmental venous anomalies (DVA) are congenital malformations of veins that drain brain parenchyma, with a prevalence up to 9.3% in normal populations and 29.5% in multiple sclerosis (MS) patients. Study purpose was to determine prevalence of DVAs in patients with clinically isolated syndrome (CIS) and early relapsing-remitting multiple sclerosis (RRMS) and to assess whether DVAs are related to altered clinical, magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) laboratory parameters. Methods Routine neurological and MRI examinations took place in a single center in 93 patients (39 CIS, 54 RRMS). Clinical disability (n = 93), MRI (n ≤ 90), CSF (n ≤ 82) parameters and DVA status were determined and compared statistically. Results A total of 29 DVAs were detected in 25 patients (25/93; 26.9%), 10 in 39 CIS patients and 15 in 54 RRMS patients. Most parameters were not significantly altered in patients with DVAs; no associated higher conversion rates from CIS to MS at 1–year (p = 0.411) or 2‑year follow-up (p = 0.281) were registered. Conclusion A higher prevalence of DVAs was detected in CIS and early MS patients than reported in non-MS populations, congruent to recent literature. The DVAs were not associated with significantly altered clinical outcomes, brain atrophy rates or disease progression, and no associated higher risk of CIS patients for converting to MS was found.
- Open Access
- 27 May 2008
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 2 (1) , 180
Mediastinal pancreatic pseudocyst with isolated thoracic symptoms: a case report
Mediastinal pancreatic pseudocysts represent a rare complication of acute or chronic pancreatitis.
- 27 May 2008
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 2 (1) , 180
Open AccessMediastinal pancreatic pseudocyst with isolated thoracic symptoms: a case report
Mediastinal pancreatic pseudocysts represent a rare complication of acute or chronic pancreatitis.